Search research articles
Contact Us
Filters
Showing results (61-70 of 65) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 65 results.
Macromolecular Bioscience
|
June 10, 2010
Interaction of an endosomolytic polyamidoamine ISA23 with vesicles mimicking intracellular membranes: A SANS/EPR study
Peter C Griffiths, Renuka Nilmini, Emma Carter, et al.
Biomacromolecules
|
March 15, 2005
Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates
Lars Andersson, John Davies, Ruth Duncan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 28, 2004
LEAPT: lectin-directed enzyme-activated prodrug therapy
Mark A Robinson, Stuart T Charlton, Philippe Garnier, et al.
Nanomedicine (London, England)
|
May 10, 2013
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines
Falk Ehmann, Kumiko Sakai-Kato, Ruth Duncan, et al.
International Journal of Oncology
|
May 9, 2009
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
Leonard W Seymour, David R Ferry, David J Kerr, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 65) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 65 results.
Macromolecular Bioscience
|
June 10, 2010
Interaction of an endosomolytic polyamidoamine ISA23 with vesicles mimicking intracellular membranes: A SANS/EPR study
Peter C Griffiths, Renuka Nilmini, Emma Carter, et al.
Biomacromolecules
|
March 15, 2005
Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates
Lars Andersson, John Davies, Ruth Duncan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 28, 2004
LEAPT: lectin-directed enzyme-activated prodrug therapy
Mark A Robinson, Stuart T Charlton, Philippe Garnier, et al.
Nanomedicine (London, England)
|
May 10, 2013
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines
Falk Ehmann, Kumiko Sakai-Kato, Ruth Duncan, et al.
International Journal of Oncology
|
May 9, 2009
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
Leonard W Seymour, David R Ferry, David J Kerr, et al.
Page
of 7